The burden of neuropathic pain: A systematic review and meta-analysis of health utilities

被引:254
|
作者
Doth, Alissa H. [3 ,4 ]
Hansson, Per T. [5 ,6 ]
Jensen, Mark P. [7 ]
Taylor, Rod S. [1 ,2 ]
机构
[1] Univ Exeter, Peninsula Med Sch, Exeter EX2 5DW, Devon, England
[2] Univ Plymouth, Peninsula Med Sch, Exeter EX2 5DW, Devon, England
[3] Univ Minnesota, Minneapolis, MN 55455 USA
[4] Medtron Neuromodulat, Minneapolis, MN USA
[5] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[6] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden
[7] Univ Washington, Sch Med, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
Neuropathic pain; Utility; Health-related quality of life; Meta-analysis; EQ-5D; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIALS; EFNS GUIDELINES; EQ-5D; POPULATION;
D O I
10.1016/j.pain.2010.02.034
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Patients with neuropathic pain (NeuP) experience substantially lower health-related quality of life (HRQoL) than the general population. The aim of this systematic review and meta-analysis is to test the hypothesis that NeuP is associated with low levels of health utility. A structured search of electronic databases (MEDLINE, EMBASE, Cochrane Library and CINAHL) was undertaken. Reference lists of retrieved reports were also reviewed. Studies reporting utility single-index measures (preference based) in NeuP were included. Random effects meta-analysis was used to pool EQ-5D index utility estimates across NeuP conditions. The association of utilities and pre-defined factors (NeuP condition, patient age, sex, duration and severity of pain and method of utility scoring) was examined using meta-regression. Twenty-four studies reporting health utility values in patients with NeuP were included in the review. Weighted pooled utility score across the studies varied from a mean of 0.15 for failed back surgery syndrome to 0.61 for post-herpetic neuralgia and diabetic neuropathy. Although there was substantial heterogeneity (P < 0.0001) across studies, we found little variation in utility as a function of patient and study characteristics. The single exception was a significant relationship (P < 0.0001) between increasing neuropathic pain severity and a reduction in utility. This study confirms the hypothesis that patients with NeuP experience low utilities and therefore low HRQoL. However, the contribution of non-NeuP co-morbidity remains unclear. Neuropathic pain severity emerged as a primary predictor of the negative health impact of NeuP. (C) 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:338 / 344
页数:7
相关论文
共 50 条
  • [1] THE HEALTH BURDEN OF NEUROPATHIC PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES
    Taylor, R. S.
    Jensen, M.
    Doth, A. H.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A136 - A137
  • [2] A Systematic Review and Meta-analysis of Childhood Health Utilities
    Kwon, Joseph
    Kim, Sung Wook
    Ungar, Wendy J.
    Tsiplova, Kate
    Madan, Jason
    Petrou, Stavros
    [J]. MEDICAL DECISION MAKING, 2018, 38 (03) : 277 - 305
  • [3] Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
    Finnerup, Nanna B.
    Attal, Nadine
    Haroutounian, Simon
    McNicol, Ewan
    Baron, Ralf
    Dworkin, Robert H.
    Gilron, Ian
    Haanpaa, Maija
    Hansson, Per
    Jensen, Troels S.
    Kamerman, Peter R.
    Lund, Karen
    Moore, Andrew
    Raja, Srinivasa N.
    Rice, Andrew S. C.
    Rowbotham, Michael
    Sena, Emily
    Siddall, Philip
    Smith, Blair H.
    Wallace, Mark
    [J]. LANCET NEUROLOGY, 2015, 14 (02): : 162 - 173
  • [4] CANNABINOIDS AND SLEEP HEALTH IN PATIENTS WITH CHRONIC NEUROPATHIC PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    McParland, Aidan
    Daniel, Kapustin
    Bhatia, Anuj
    Clarke, Hance
    Aditya, Trivedi
    Brull, Richard
    Singh, Mandeep
    [J]. SLEEP, 2021, 44 : A271 - A272
  • [5] Systematic review and meta-analysis of genetic risk factors for neuropathic pain
    Veluchamy, Abirami
    Hebert, Harry L.
    Meng, Weihua
    Palmer, Colin N. A.
    Smith, Blair H.
    [J]. PAIN, 2018, 159 (05) : 825 - 848
  • [6] Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
    Di Stefano, Giulia
    Di Lionardo, Andrea
    Di Pietro, Giuseppe
    Cruccu, Giorgio
    Truini, Andrea
    [J]. PAIN RESEARCH & MANAGEMENT, 2021, 2021
  • [7] Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
    Meng, Howard
    Johnston, Bradley
    Englesakis, Marina
    Moulin, Dwight E.
    Bhatia, Anuj
    [J]. ANESTHESIA AND ANALGESIA, 2017, 125 (05): : 1638 - 1652
  • [8] A Systematic Review and Meta-Analysis of Efficacy of Botulinum Toxin A for Neuropathic Pain
    Datta Gupta, Anupam
    Edwards, Suzanne
    Smith, Jessica
    Snow, John
    Visvanathan, Renuka
    Tucker, Graeme
    Wilson, David
    [J]. TOXINS, 2022, 14 (01)
  • [9] Evaluating the impact of gabapentinoids on sleep health in patients with chronic neuropathic pain: a systematic review and meta-analysis
    Kapustin, Daniel
    Bhatia, Anuj
    McParland, Aidan
    Trivedi, Aditya
    Davidson, Alexandra
    Brull, Richard
    Singh, Mandeep
    [J]. PAIN, 2020, 161 (03) : 476 - 490
  • [10] Hypnosis to manage musculoskeletal and neuropathic chronic pain: A systematic review and meta-analysis
    Langlois, Pascaline
    Perrochon, Anaick
    David, Romain
    Rainville, Pierre
    Wood, Chantal
    Vanhaudenhuyse, Audrey
    Pageaux, Benjamin
    Ounajim, Amine
    Lavalliere, Martin
    Debarnot, Ursula
    Luque-Moreno, Carlos
    Roulaud, Manuel
    Simoneau, Martin
    Goudman, Lisa
    Moens, Maarten
    Rigoard, Philippe
    Billot, Maxime
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2022, 135